IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 385
Titolo Data di pubblicazione Autore(i) File
Possible multiple myeloma dedifferentiation following thalidomide therapy: a report of four cases 1-gen-2004 Balleari, E; Ghio, R; Falcone, A; Musto, P
Tandem bone marrow transplantation in multiple myeloma 1-gen-2004 Musto, P
Revisiting the use of recombinant erythropoietin in myelodysplastic syndromes 1-gen-2005 Musto, P
Thalidomide plus dexamethasone is an effective salvage regimen for myeloma patients relapsing after autologous transplant 1-gen-2005 Palumbo, A; Falco, P; Ambrosini, Mt; Petrucci, Mt; Musto, P; Caravita, T; Pregno, P; Bertola, A; Cavallo, F; Ciccone, G; Boccadoro, M
Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma 1-gen-2005 Palumbo, A; Bertola, A; Musto, P; Caravita, T; Callea, V; Nunzi, M; Grasso, M; Falco P, ; Cangialosi, C; Boccadoro, M.
Reduced intensity conditioning for allograft after cytoreductive autograft in metastatic breast cancer 1-gen-2005 Carella, Am; Beltrami, G; Corsetti, Mt; Nati, S; Musto, P; Scalzulli, P; Gonella, R; Ballestrero, A; Patrone, F
Correlation between fatigue and hemoglobin level in multiple myeloma patients: results of a cross-sectional study 1-gen-2005 Palumbo, A; Petrucci, Mt; Lauta, Vm; Musto, P; Caravita, T; Barbui, Am; Nunzi, M; Boccadoro, M
A reduced intensity conditioning regimen for allografting following autografting is feasible and has strong anti-myeloma activity 1-gen-2005 Carella, Am; Beltrami, G; Corsetti, Mt; Scalzulli, P; Carella AM, Jr; Musto, P
Evaluation of the monocyte counting by two automated haematology analysers compared with flow cytometry 1-gen-2005 Grimaldi, E.; Carandente, P.; Scopacasa, F.; Romano, M. F.; Musto, P.; Bisogni, R.; De Caterina, M.
Impact of a new dosing regimen of epoetin alfa on quality of life and anemia in patients with low-risk myelodysplastic syndrome 1-gen-2005 Spiriti, Ma; Latagliata, R; Niscola, P; Cortelezzi, A; Francesconi, M; Ferrari, D; Volpe, E; Clavio, M; Grossi, A; Reyes, Mt; Musto, P; Mitra, Me; Azzarà, A; Pagnini, D; D'Arena, G; Spadano, A; Balleari, E; Pecorari, P; Capochiani, E; De Biasi, E; Perego, D; Monarca, B; Pisani, F; Scaramella, G; Petti, Mc
Darbepoetin alpha for the treatment of anaemia in low-intermediate risk myelodysplastic syndromes 1-gen-2005 Musto, P; Lanza, F; Balleari, E; Grossi, A; Falcone, A; Sanpaolo, G; Bodenizza, C; Scalzulli, Pr; La Sala, A; Campioni, D; Ghio, R; Cascavilla, N; Carella, Am
Intermediate-dose melphalan (100 mg/m2)/bortezomib/thalidomide/dexamethasone and stem cell support in patients with refractory or relapsed myeloma 1-gen-2006 Palumbo, A.; Avonto, I.; Bruno, B.; Falcone, A.; Scalzulli, P. R.; Ambrosini, M. T.; Bringhen, S.; Gay, F.; Cavallo, F.; Falco, P.; Massaia, M.; Musto, P.; Boccadoro, M.
New treatment strategies for elderly myeloma patients 1-gen-2006 Palumbo, A.; Falco, P.; Musto, P.; Rossi, G.; Giuliani, N.; Morabito, F.; Falcone, A.; Gay, F.; Avonto, I.; Ambrosini, M. T.; Capozzi, R.; Callea, V.; Cangialosi, C.; Montanaro, M.; Catalano, L.; Grasso, M.; Petti, M. C.; Merla, M.; Falchi, L.; Petrucci, M. T.; Caravita, T.; Bringhen, S.; Corradini, P.; Raimondo, F. D. I.; Boccadoro, M.
High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma 1-gen-2006 Marcucci, F; Mele, A; Spada, E; Candido, A; Bianco, E; Pulsoni, A; Chionne, P; Madonna, E; Cotichini, R; Barbui, A; De Renzo, A; Dore, F; Iannitto, E; Liso, V; Martino B, ; Montanaro, M; Pagano, L; Musto, P; Rapicetta, M
Combination of erythropoietin and thalidomide for the treatment of anemia in patients with myelodysplastic syndromes 1-gen-2006 Musto, P; Falcone, A; Sanpaolo, G; Bodenizza, C
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial 1-gen-2006 Palumbo, A; Bringhen, S; Caravita, T; Merla, E; Capparella, V; Callea, V; Cangialosi, C; Grasso, M; Rossini, F; Galli, M; Catalano, L; Zamagni, E; Petrucci, Mt; De Stefano, V; Ceccarelli, M; Ambrosini, Mt; Avonto, I; Falco, P; Ciccone, G; Liberati AM, ; Musto, P; Boccadoro, M
Bortezomib (Velcade) for progressive myeloma after autologous stem cell transplantation and thalidomide 1-gen-2006 Musto, P; Falcone, A; Sanpaolo, G; Guglielmelli, T; Zambello, R; Balleari, E; Catalano, L; Spriano, M; Cavallo, F; La Sala, A; Mantuano, S; Nobile, M; Melillo, L; Scalzulli, Pr; Dell'Olio, M; Bodenizza, C; Greco, Mm; Carella AM, Jr; Merla, E; Carella AM, ; Boccadoro, M; Cascavilla, N; Palumbo, A
Two novel imatinib-responsive PDGFRA fusion genes in chronic eosinophilic leukaemia 1-gen-2007 Curtis, Ce; Grand, Fh; Musto, P; Clark, A; Murphy, J; Perla, G; Minervini, Mm; Stewart, J; Reiter, A; Cross, Nc
Thalidomide therapy in adult patients with myelodysplastic syndrome: a north central cancer treatment group phase II trial 1-gen-2007 Musto, P
Rare HVR1-HCV genotype 1b variants in patients with B non Hodgkin's lymphoma. Comparison with viral sequences detected in cases of lymphoproliferative disorders and B cell compartmentalisation 1-gen-2007 Dettori, S; Argentini, C; Marcucci, F; Spada, E; Chionne, P; Candido, A; Madonna, E; Ciccaglione, Ar; Bianco, E; Iannitto, E; Musto, P; Liso, V; De Renzo, A; Pagano, L; Nieddu, G; Pulsoni, A; Mele, A; Rapicetta, M
Mostrati risultati da 21 a 40 di 385
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile